Ponesimod reduces annualized relapse rate, compared with teriflunomideSeptember 12, 2019Multiple Sclerosis
Continuous treatment reduces risk of confirmed disability progression in MSSeptember 12, 2019Multiple Sclerosis
Interview with Andrew Solomon, MD, on diagnosing multiple sclerosis September 9, 2019Multiple Sclerosis
Switching From Interferon Beta-1a to Alemtuzumab Improves MS OutcomesAugust 28, 2019Multiple Sclerosis
Patients With MS Who Consider Marijuana Use More Likely to Engage in Risky BehaviorsAugust 28, 2019Multiple Sclerosis
Serum neurofilament light chain level may indicate MS disease activityAugust 14, 2019Multiple Sclerosis
